ArticleEndocrine connections2026
Long-term persistent hypertension following surgical resection of pheochromocytoma and paraganglioma.
Article in Endocrine connections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Differences in management and outcomes between pheochromocytomas and sympathetic paragangliomas.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-metastatic pheochromocytomas and paragangliomas (PPGLs) are considered a curable cause of secondary hypertension. However, some studies identified that a considerable ratio of patients (10.0-43.8%) still experience persistent hypertension even after successful resection of PPGLs. Methods: We conducted a retrospective analysis of 472 PPGL patients who underwent surgical resection at three centers from January 1, 2012, to October 31, 2022. Comprehensive clinical data were recorded. Binary unconditional logistic analysis was conducted to identify the independent variables associated with long-term persistent hypertension. Results: The cohort had an average age of 50.5 years, and the median follow-up duration was 61 months. A total of 26.3% of PPGL patients experienced long-term persistent hypertension. After multivariate analysis, we identified older age (odds ratio (OR): 1.021, P = 0.008), higher body mass index (BMI, OR: 1.088, P = 0.004), lower left ventricular ejection fraction (LVEF, OR: 3.506, P = 0.006), and developed intraoperative hemodynamic instability (HDI, OR: 2.053, P = 0.002) as independent risk factors for long-term persistent hypertension in PPGL patients. Conclusion: This study demonstrated that nearly a quarter of PPGL patients still suffer from persistent hypertension after successful resection and identified several risk factors, such as older age, higher BMI, lower LVEF, and developed intraoperative HDI. These results might contribute to improving long-term follow-up strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.